|
⚲
|
| Keyboard |
| Hirsch Stanley
✚
|
|
|---|---|
| CIK # | 0001727864 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001727864] | |
| 4 | [0001727864] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hirsch Stanley | |
| VYNE Therapeutics Inc | |
| Foamix Pharmaceuticals Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-04-03 | Grant | 63,844 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-04-03 | Grant | 71,303 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-04-03 | Grant | 220,496 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-03-09 | Disposed to issuer | 182,500 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-03-09 | Disposed to issuer | 59,016 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-03-09 | Disposed to issuer | 52,842 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Options · derivative
|
2020-03-09 | Disposed to issuer | 82,153 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Options · derivative
|
2020-03-09 | Disposed to issuer | 27,000 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Options · derivative
|
2020-03-09 | Disposed to issuer | 49,766 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-03-09 | Grant | 34,960 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-03-09 | Grant | 31,303 | ||
|
VYNE Therapeutics Inc MNLO
Common Stock
|
2020-03-09 | Grant | 108,113 | ||
|
VYNE Therapeutics Inc MNLO
Stock Options · derivative
|
2020-03-09 | Grant | 48,667 | ||
|
VYNE Therapeutics Inc MNLO
Stock Options · derivative
|
2020-03-09 | Grant | 29,481 | ||
|
VYNE Therapeutics Inc MNLO
Stock Options · derivative
|
2020-03-09 | Grant | 15,994 | ||
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2020-02-27 | Grant | 42,493 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2019-11-04 | Option exercise | 32,500 | $0.62 | 20,150 |
|
Foamix Pharmaceuticals Ltd FOMX
Options · derivative
|
2019-11-04 | Option exercise | 32,500 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Options · derivative
|
2019-10-15 | Option exercise | 90,000 | $0.00 | |
|
Foamix Pharmaceuticals Ltd FOMX
Ordinary Shares
|
2019-10-15 | Option exercise | 90,000 | $0.62 | 55,800 |
| showing 20 of 29 most recent transactions | |||||